Citryll
Developer of monoclonal antibody for immune-mediated inflammatory diseases by targeting Neutrophil extracellular traps (NETs).
1
Funding Rounds
$110.4m
Money raised
Overview
Developer of monoclonal antibody for immune-mediated inflammatory diseases by targeting Neutrophil extracellular traps (NETs).
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Citryll has raised a total of $20.9m in funding over 1 rounds.
Key Insights:
- Citryll , July 2020: $20.9m
Citryll , July 2020
$20.9m
Industries
Citryll is active in the following industries: